Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Pharming’s Leniolisib On Track To Become First Disease-Modifying APDS Drug
Following NDA Acceptance
Sep 28 2022
•
By
Ayisha Sharma
Pharming Seems To Be The Only Firm Working On A Drug For APDS • Source: Shutterstock
More from New Products
More from Scrip